<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02876575</url>
  </required_header>
  <id_info>
    <org_study_id>COVBZTS0562</org_study_id>
    <nct_id>NCT02876575</nct_id>
  </id_info>
  <brief_title>A Study of BiZact™ on Adults Undergoing Tonsillectomy</brief_title>
  <official_title>A Prospective, Multi-center, Single Arm Non-comparative Pilot Study of BiZact™ on Adults Undergoing Tonsillectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the severity of post-operative pain following the use
      of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in
      Europe) tonsillectomy procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Design: Prospective, multi-center, single-arm non-comparative pilot study to assess the
      severity of post-operative pain with the use of BiZact™ for tonsillectomy.

      Study Visits:

        -  Screening

        -  Surgery, Day 0

        -  Post-Op Follow-up Day 1 - Day 7 &amp; Day 10 (Home assessments)

        -  Post-Op Follow-up Day 14 (Office Visit)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 13, 2017</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of post-operative pain following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 1</time_frame>
    <description>Pain assessment using a Visual Analog Scale (VAS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of post-operative pain following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 2</time_frame>
    <description>Pain assessment using a Visual Analog Scale (VAS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of post-operative pain following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 3</time_frame>
    <description>Pain assessment using a Visual Analog Scale (VAS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of post-operative pain following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 4</time_frame>
    <description>Pain assessment using a Visual Analog Scale (VAS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of post-operative pain following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 5</time_frame>
    <description>Pain assessment using a Visual Analog Scale (VAS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of post-operative pain following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 6</time_frame>
    <description>Pain assessment using a Visual Analog Scale (VAS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of post-operative pain following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 7</time_frame>
    <description>Pain assessment using a Visual Analog Scale (VAS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of post-operative pain following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 10</time_frame>
    <description>Pain assessment using a Visual Analog Scale (VAS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of post-operative pain following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 14</time_frame>
    <description>Pain assessment using a Visual Analog Scale (VAS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ability to return to normal diet and activity following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 1</time_frame>
    <description>EORTC Quality of Life Questionnaire (EORTC QLQ -H&amp;N35)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to return to normal diet and activity following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 2</time_frame>
    <description>EORTC Quality of Life Questionnaire (EORTC QLQ -H&amp;N35)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to return to normal diet and activity following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 3</time_frame>
    <description>EORTC Quality of Life Questionnaire (EORTC QLQ -H&amp;N35)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to return to normal diet and activity following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 4</time_frame>
    <description>EORTC Quality of Life Questionnaire (EORTC QLQ -H&amp;N35)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to return to normal diet and activity following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 5</time_frame>
    <description>EORTC Quality of Life Questionnaire (EORTC QLQ -H&amp;N35)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to return to normal diet and activity following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 6</time_frame>
    <description>EORTC Quality of Life Questionnaire (EORTC QLQ -H&amp;N35)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to return to normal diet and activity following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 7</time_frame>
    <description>EORTC Quality of Life Questionnaire (EORTC QLQ -H&amp;N35)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to return to normal diet and activity following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 10</time_frame>
    <description>EORTC Quality of Life Questionnaire (EORTC QLQ -H&amp;N35)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to return to normal diet and activity following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.</measure>
    <time_frame>Post-operative Day 14</time_frame>
    <description>EORTC Quality of Life Questionnaire (EORTC QLQ -H&amp;N35)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Tonsillectomy</condition>
  <arm_group>
    <arm_group_label>A bipolar instrument for tonsillectomies</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>A bipolar instrument for tonsillectomies</intervention_name>
    <description>A bipolar electrosurgical device that employs RF energy and pressure to ligate vessels interposed between its jaws which can then be transected using the built in knife deployed by the device trigger.</description>
    <arm_group_label>A bipolar instrument for tonsillectomies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adults (male or female) ≥22 in United States and ≥18 years of age in Europe years of
             age

          2. Scheduled to undergo tonsillectomy

          3. Signed informed consent by subject

        Exclusion Criteria:

          1. Subjects undergoing:

               1. Simultaneous adenoidectomy

               2. Tonsillectomy as a result of cancer

               3. Unilateral tonsillectomy

               4. Current participation in other clinical trials

          2. Subjects with:

               1. Current tobacco use

               2. Known bleeding disorders

               3. History of peritonsillar abscess

               4. Craniofacial disorders

               5. Down syndrome (Trisomy 21)

               6. Cerebral palsy

               7. Major heart disease (including but not limited to; right-sided heart failure,
                  left-sided heart failure, congestive heart failure, coronary artery disease,
                  arrhythmias, chronic heart failure, acute heart failure, etc.)

               8. Subjects unable to comply with the required study follow-up visits

               9. Pregnancy

          3. The subject has comorbidities which, in the opinion of the investigator, will not be
             appropriate for the study or the subject has an estimated life expectancy of less than
             6 months

          4. Any subject who is considered to be part of a vulnerable population (e.g. prisoners or
             those without sufficient mental capacity)

          5. The subject has participated in any drug or device research study within 30 days of
             enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UT Health</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Syed Naqvi</last_name>
      <phone>713-500-5414</phone>
      <email>Syed.Naqvi@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Ron Karni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sophia Hemmet</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Per Attner, MD, PhD</last_name>
      <phone>0708-259552</phone>
      <email>per.attner@sophiahemmet.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2016</study_first_submitted>
  <study_first_submitted_qc>August 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2016</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>At study completion.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

